Huichun Zhan

1.1k citations
40 papers · 682 indexed · h-index 15
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers)Acute Myeloid Leukemia Research (20 papers)Chronic Myeloid Leukemia Treatments (10 papers)
Partner nations
United StatesChina

In The Last Decade

Huichun Zhan

34 papers receiving 673 citations

Peers

Huichun Zhan
Comparison fields: 5 of 71
  • Molecular Biology 411
  • Genetics 279
  • Hematology 239
  • Rheumatology 80
  • Physiology 68
Replace Qian-Fei Wang with:
Qian-Fei Wang United States
Anke K. Bergmann Germany
Grazia Abou‐Ezzi United States
N Nagata Japan
José‐Marc Techner United States
Norihiro Awaya Japan
Omid F. Harandi United States
Vesna Spasovski Serbia
Jinyun Chen China
Rongjia Zhu China
Huichun Zhan relative to Qian-Fei Wang United States Qian-Fei Wang's profile →
Citations per field
00.5×6.7×
Qian-Fei Wang · 1×
Citations per year

Countries citing papers authored by Huichun Zhan

Since Specialization
Citations

This map shows the geographic impact of Huichun Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huichun Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huichun Zhan more than expected).

Fields of papers citing papers by Huichun Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huichun Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huichun Zhan. The network helps show where Huichun Zhan may publish in the future.

Co-authorship network of co-authors of Huichun Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Huichun Zhan. A scholar is included among the top collaborators of Huichun Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huichun Zhan. Huichun Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 3
4 0
5 1
6 5
7 3
8 27
9 18
10 4
11 28
12 4
13 39
14 0
15 19
16 20
17 276
18 14
19 20
20 42

About Huichun Zhan

Huichun Zhan is a scholar working on Genetics, Hematology and Transplantation, having authored 40 papers that have together received 682 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Acute Myeloid Leukemia Research (20 papers) and Chronic Myeloid Leukemia Treatments (10 papers). The work is most often cited by research in Genetics (279 citations), Hematology (239 citations) and Molecular Biology (411 citations). Huichun Zhan has collaborated with scholars based in United States and China. Frequent co-authors include Kenneth Kaushansky, Jerry L. Spivak, Chi Hua Sarah Lin, Alison R. Moliterno, Chi V. Dang, Prashant Mali, Zhaohui Ye, Yoon-Young Jang, Linzhao Cheng and Donna M. Williams. Their work appears in journals such as Blood, Annals of the New York Academy of Sciences and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026